tiprankstipranks
Trending News
More News >
Jade Biosciences (JBIO)
NASDAQ:JBIO
US Market

Jade Biosciences (JBIO) Income Statement

Compare
173 Followers

Jade Biosciences Income Statement

Last quarter (Q3 2025), Jade Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Jade Biosciences's net income was $-25.18M. See Jade Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -282.00K$ -96.00K$ -68.00K$ -15.00K$ -1.00K
Operating Expenses
$ 74.31M$ 81.31M$ 53.17M$ 23.01M$ 8.89M
Depreciation and Amortization
$ 282.00K$ 96.00K$ 68.00K$ 15.00K$ 1.00K
EBITDA
$ -69.29M$ -75.37M$ -51.42M$ -22.95M$ -9.54M
Operating Income
$ -74.60M$ -81.41M$ -53.24M$ -23.02M$ -8.89M
Other Income/Expenses
$ 5.02M$ 5.94M$ 1.75M$ 62.00K$ -722.00K
Pretax Income
$ -69.57M$ -75.47M$ -51.49M$ -22.96M$ -9.61M
Net Income
$ -69.63M$ -75.52M$ -51.51M$ -22.96M$ -9.61M
Per Share Metrics
Basic EPS
$ -85.26$ -100.38$ -73.67$ -32.96$ -14.00
Diluted EPS
$ -85.26$ -100.38$ -73.67$ -32.96$ -14.00
Weighted Average Shares Outstanding
816.63K 752.33K 699.20K 697.44K 697.44K
Weighted Average Shares Outstanding (Diluted)
816.63K 752.33K 699.20K 697.44K 697.44K
Currency in USD

Jade Biosciences Earnings and Revenue History